Study guide

Prosthetic Valves and Postoperative Evaluation

RDCS Adult Echocardiography AE

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

The RDCS AE Exam, SPI Requirement & Logistics Content Outline, Domain Weights & How to Study

2 Cardiac Anatomy

Chambers, Walls, Myocardial Layers & the 17-Segment Model Cardiac Valves & Subvalvular Apparatus Great Vessels, Pericardium, Coronary & Venous Anatomy

3 Cardiac Physiology & Hemodynamics

Cardiac Cycle, Phases & Pressure-Volume Relationships Normal Systolic & Diastolic Function Hemodynamic Principles & Response to Stress

4 Echo Modalities, Instrumentation & Contrast

2D (B-Mode) and M-Mode Imaging Spectral, Color, and Tissue Doppler Modalities Image Optimization, Artifacts, and Contrast Echocardiography

5 Standard Views, Windows & Protocol

Parasternal Long- & Short-Axis Views Apical Views Subcostal & Suprasternal-Notch Views Exam Protocol, Patient Positioning & Provocative Maneuvers

6 Quantification & Doppler Hemodynamic Calculations

Chamber Quantification: LV, LA, RA, and RV Size, Mass, and Volumes Systolic Function: Ejection Fraction Methods, Fractional Shortening & Strain Diastolic Function Grading (ASE/EACVI 2016) Core Doppler Math: Modified Bernoulli, VTI, Stroke Volume & the Continuity Equation Advanced Hemodynamics: PISA/EROA, Pressure Half-Time, dP/dt, Qp/Qs & RVSP

7 Aortic & Mitral Valve Disease

Aortic Stenosis Aortic Regurgitation Mitral Stenosis Mitral Regurgitation

8 Right-Sided, Prosthetic & Infective Valve Disease

Tricuspid & Pulmonic Valve Disease and Pulmonary Hypertension Assessment Infective Endocarditis and Vegetations Prosthetic Valves and Postoperative Evaluation

9 Ischemic Disease & Cardiomyopathies

Coronary Anatomy, Ischemic Heart Disease & Wall-Motion Abnormalities Stress Echocardiography & Myocardial Viability Mechanical Complications of Myocardial Infarction Dilated & Restrictive Cardiomyopathy Hypertrophic Cardiomyopathy, SAM & LVOT Obstruction

10 Pericardial Disease, Masses & Aorta

Pericardial Effusion & Cardiac Tamponade Constrictive Pericarditis vs. Restrictive Physiology Cardiac Masses, Tumors & Thrombi Aortic Disease: Aneurysm, Dissection & Atheroma

11 Congenital Heart Disease & Shunts

Septal Defects & Shunt Quantification Common Adult Congenital Lesions

12 Clinical Care & Safety

Patient Care, Clinical-Data Integration & Exam Protocols Bioeffects, ALARA, Infection Control & Ergonomics

Prosthetic Valves and Postoperative Evaluation

Key Takeaways Explain This Topic AI

Patient-prosthesis mismatch (PPM) is graded by indexed effective orifice area: aortic PPM is moderate at 0.65-0.85 cm^2/m^2 and severe below 0.65 cm^2/m^2; mitral PPM is moderate at 0.9-1.2 cm^2/m^2 and severe at or below 0.9 cm^2/m^2.

A normal mechanical aortic prosthesis has a mean gradient under 20 mmHg and a dimensionless velocity index (DVI) of 0.30-0.35; severe obstruction shows a mean gradient over 35 mmHg and a DVI under 0.25.

A normal prosthetic mitral valve has a mean gradient under 5-6 mmHg and a pressure half-time under 130 ms; severe obstruction shows a mean gradient over 10 mmHg and a pressure half-time over 200 ms.

Small, symmetric 'washing jets' are a normal, expected finding on mechanical valves and must be distinguished from pathologic paravalvular regurgitation, which is typically eccentric and located outside the sewing ring.

Obstructive thrombus is usually visualized as a mobile mass on TEE with associated leaflet restriction on fluoroscopy, whereas pannus is a later, fixed fibrous ingrowth that is frequently not visualized as a discrete mass.

Last updated: July 2026

Mechanical vs. Bioprosthetic Valves

Prosthetic valves fall into two broad categories with different echocardiographic expectations:

Feature Mechanical Bioprosthetic

Common designs Bileaflet (most common today), tilting-disc, caged-ball (older/rare) Stented porcine/pericardial, stentless, transcatheter (TAVR)

Durability Excellent, rarely degenerates structurally Structural valve deterioration typically over 10-20 years

Anticoagulation Lifelong warfarin required (target INR varies by position/thrombogenicity) Not required long-term (beyond an initial post-op period)

Typical patient Younger, low bleeding risk Older, or anticoagulation contraindicated

Normal color Doppler jets Small, symmetric 'washing' jets through the closure mechanism are expected and normal Trivial central regurgitation may be normal; any jet should be small and central

The mechanical valve's normal washing jets are a critical distinction from pathology: they are typically multiple, small, symmetric, and central to the sewing ring. Any regurgitant jet that is eccentric or located outside the sewing ring is paravalvular and abnormal until proven otherwise.

Normal vs. Abnormal Gradients

Prosthetic valve gradients are flow- and heart-rate dependent, so reference values are compared against a patient's own post-operative baseline whenever available. Representative normal and severe-obstruction values:

  • Position Parameter Normal Severe Obstruction
  • Aortic Mean gradient <20 mmHg >35 mmHg
  • Aortic Dimensionless velocity index (DVI) 0.30-0.35 <0.25
  • Aortic Effective orifice area Valve/size-specific <0.8 cm^2
  • Mitral Mean gradient <5-6 mmHg >10 mmHg
  • Mitral Pressure half-time (PHT) <130 ms >200 ms
  • Mitral Peak velocity — >2.5 m/s

DVI (LVOT VTI divided by prosthetic-valve VTI) is especially useful for the aortic position because it is independent of LVOT diameter measurement error and remains valid even when the exact valve size/type is unknown.

Prosthetic Valve Dysfunction

Four mechanisms account for most acquired prosthetic dysfunction:

Thrombosis — typically early post-implant, associated with subtherapeutic anticoagulation; TEE shows a mobile, often soft echo-density mass, and fluoroscopy/cine typically shows restricted leaflet motion in nearly all cases.

Pannus — fibrous tissue ingrowth that develops later after implantation; frequently produces leaflet restriction without a discrete TEE-visible mass, and is not treated with fibrinolysis.

Structural degeneration (bioprosthetic) — leaflet calcification, tearing, or perforation causing stenosis, regurgitation, or both; evaluated the same way as native leaflet disease.

Dehiscence — partial separation of the sewing ring from the annulus; produces an abnormal 'rocking' motion of the prosthesis (rocking greater than 15 degrees is considered hemodynamically significant) and a new paravalvular regurgitant jet.

  • Feature Thrombus Pannus
  • Onset after implant Early Late
  • Anticoagulation history Often subtherapeutic Often therapeutic
  • TEE mass visualization Usually present, soft echo-density Often absent or subtle
  • Fluoroscopic leaflet restriction Nearly always present Variable
  • Treatment Fibrinolysis or reoperation Surgery only (fibrinolysis contraindicated)
  • Patient–Prosthesis Mismatch (PPM)

PPM occurs when a normally functioning prosthesis is simply too small for the patient's body size, so its effective orifice area (EOA) cannot accommodate the necessary cardiac output without generating elevated gradients. Severity is graded by indexed EOA (EOA divided by body surface area):

  • Position None Moderate Severe
  • Aortic >0.85 cm^2/m^2 0.65-0.85 cm^2/m^2 <0.65 cm^2/m^2
  • Mitral >1.2 cm^2/m^2 0.9-1.2 cm^2/m^2 <=0.9 cm^2/m^2

PPM is a leading cause of persistently elevated gradients after valve replacement even when the prosthesis itself is structurally and functionally normal — it must be distinguished from true valve obstruction (thrombosis, pannus, degeneration), which shows abnormal leaflet motion or structure rather than a preserved but undersized orifice. Because mechanical mitral prostheses generate significant acoustic shadowing on TTE, TEE is often required to fully assess the left atrial side of a mitral prosthesis for thrombus, vegetation, or paravalvular leak that TTE cannot resolve.

Surveillance and Reporting

Every prosthetic valve evaluation should begin from a documented early post-operative baseline study, typically obtained in the first several weeks after implantation once acute hemodynamic changes have stabilized, with subsequent surveillance studies (often annual, or sooner if new symptoms develop) compared directly against that baseline rather than against generic population reference values. A rising gradient trend over serial studies is a more reliable dysfunction signal than any single absolute measurement, since valve size, cardiac output, and patient body size all shift the 'normal' range for a given prosthesis.

A complete prosthetic valve report should include valve type and position, peak and mean gradients, DVI or EOA, any regurgitation (its severity and whether it is central/expected versus eccentric/paravalvular), and a qualitative assessment of leaflet or disc motion. Transcatheter aortic valves (TAVR) follow the same Doppler framework as surgical bioprostheses, with the added consideration of frame stent geometry and a higher relative frequency of mild paravalvular regurgitation immediately post-implant, which typically requires the same eccentric-jet-location logic used for surgical paravalvular leak. When gradients are discordant with clinical status, or when DVI and mean gradient disagree about severity, stress echocardiography or CT can help separate true structural obstruction from a flow-related or measurement artifact.